טוען...

IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis

Psoriasis is an immune-mediated skin disorder associated with severe systemic comorbidities. Whereas IL-36 is a key disease driver, the pathogenic role of this cytokine has mainly been investigated in skin. Thus, its effects on systemic immunity and extracutaneous disease manifestations remain poorl...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	J Invest Dermatol
Main Authors:	Catapano, Marika, Vergnano, Marta, Romano, Marco, Mahil, Satveer K., Choon, Siew-Eng, Burden, A. David, Young, Helen S., Carr, Ian M., Lachmann, Helen J., Lombardi, Giovanna, Smith, Catherine H., Ciccarelli, Francesca D., Barker, Jonathan N., Capon, Francesca
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2020
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7097848/ https://ncbi.nlm.nih.gov/pubmed/31539532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2019.08.444
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis

פריטים דומים